Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026)
Hims & Hers Health (HIMS) posted Amortizatization of Intangibles of $242000.0 for Q1 2026, down 66.34% sequentially from $719000.0 in Q4 2025, and down 65.08% YoY from $693000.0 in Q1 2025.
Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Amortizatization of Intangibles for 7 years, with the latest figure at $242000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 65.08% year-over-year to $242000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 60.19% YoY) and the FY2025 annual result came in at $2.0 million, down 53.34% from the prior year.
- Amortizatization of Intangibles fell to $242000.0 in Q1 2026 per HIMS's latest filing, from $719000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.7 million in Q4 2023 and troughed at -$971000.0 in Q1 2022.
- A 5-year average of $715823.5 and a median of $840000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 238.33% in 2022, then soared 1333.33% in 2023.
- Over 5 years, Amortizatization of Intangibles stood at $840000.0 in 2022, then soared by 96.67% to $1.7 million in 2023, then sank by 44.61% to $915000.0 in 2024, then retreated by 21.42% to $719000.0 in 2025, then tumbled by 66.34% to $242000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $242000.0, $719000.0, and $253000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.50 Bn | 6.66 Bn | 480.80 Mn | 96,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96,000.00 |
| Jun 30, 2026 | 96,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | 367,000.00 |
| Jun 30, 2025 | 367,000.00 |
| Mar 31, 2025 | 693,000.00 |
| Mar 31, 2025 | 693,000.00 |
| Dec 31, 2024 | 915,000.00 |
| Dec 31, 2024 | 915,000.00 |
| Sep 30, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.08 Mn |